Fred Alger Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.7M Sell
108,818
-5,008
-4% -$1.11M 0.1% 101
2025
Q4
$26M Buy
113,826
+3,265
+3% +$744K 0.1% 100
2025
Q3
$25.6M Buy
110,561
+54,335
+97% +$11.1M 0.1% 106
2025
Q2
$10.4M Sell
56,226
-367,314
-87% -$68.3M 0.05% 167
2025
Q1
$88.7M Buy
423,540
+337,893
+395% +$65.7M 0.51% 32
2024
Q4
$15.2M Sell
85,647
-17,118
-17% -$3.15M 0.07% 155
2024
Q3
$20.3M Buy
102,765
+15,332
+18% +$2.86M 0.1% 132
2024
Q2
$15M Sell
87,433
-27,662
-24% -$4.58M 0.07% 154
2024
Q1
$21M Buy
115,095
+51,407
+81% +$8.86M 0.1% 144
2023
Q4
$9.87M Sell
63,688
-34,845
-35% -$5.08M 0.05% 182
2023
Q3
$14.7M Sell
98,533
-84,443
-46% -$12.4M 0.08% 161
2023
Q2
$24.7M Sell
182,976
-765,484
-81% -$112M 0.13% 146
2023
Q1
$151M Sell
948,460
-727,003
-43% -$111M 0.81% 21
2022
Q4
$271M Buy
1,675,463
+165,489
+11% +$25.4M 1.47% 10
2022
Q3
$203M Buy
1,509,974
+229,925
+18% +$33M 1.03% 17
2022
Q2
$196M Sell
1,280,049
-276,992
-18% -$42.3M 0.92% 23
2022
Q1
$252M Sell
1,557,041
-240,564
-13% -$34.9M 0.81% 24
2021
Q4
$243M Buy
1,797,605
+1,766,693
+5,715% +$209M 0.61% 45
2021
Q3
$3.33M Sell
30,912
-89,167
-74% -$10.2M 0.01% 318
2021
Q2
$13.5M Sell
120,079
-171,432
-59% -$19.3M 0.03% 234
2021
Q1
$31.5M Sell
291,511
-460,589
-61% -$49.3M 0.08% 186
2020
Q4
$80.6M Buy
752,100
+669,584
+811% +$64.3M 0.21% 127
2020
Q3
$7.23M Sell
82,516
-87,212
-51% -$8.21M 0.02% 221
2020
Q2
$16.7M Sell
169,728
-347,056
-67% -$30.6M 0.05% 169
2020
Q1
$39.4M Sell
516,784
-659,485
-56% -$56.2M 0.17% 123
2019
Q4
$104M Buy
1,176,269
+515,272
+78% +$42.8M 0.38% 71
2019
Q3
$50.1M Buy
660,997
+611,751
+1,242% +$41.9M 0.2% 111
2019
Q2
$3.58M Buy
49,246
+34,644
+237% +$2.72M 0.01% 252
2019
Q1
$1.18M Sell
14,602
-4,555
-24% -$373K ﹤0.01% 318
2018
Q4
$1.77M Hold
19,157
0.01% 289
2018
Q3
$1.81M Sell
19,157
-3,417
-15% -$324K 0.01% 286
2018
Q2
$2.09M Sell
22,574
-1,845,687
-99% -$180M 0.01% 277
2018
Q1
$177M Buy
1,868,261
+618,563
+49% +$68M 0.82% 29
2017
Q4
$121M Buy
1,249,698
+1,108,061
+782% +$104M 0.55% 44
2017
Q3
$12.6M Buy
141,637
+138,437
+4,326% +$10.5M 0.06% 168
2017
Q2
$232K Buy
3,200
+3,000
+1,500% +$202K ﹤0.01% 386
2017
Q1
$13K Hold
200
﹤0.01% 461
2016
Q4
$13K Hold
200
﹤0.01% 419
2016
Q3
$13K Hold
200
﹤0.01% 443
2016
Q2
$12K Hold
200
﹤0.01% 472
2016
Q1
$11K Sell
200
-12,350
-98% -$688K ﹤0.01% 503
2015
Q4
$743K Buy
+12,550
New +$723K ﹤0.01% 408
2015
Q3
Sell
-219,447
Closed -$14.7M 466
2015
Q2
$14.7M Buy
+219,447
New +$14.3M 0.07% 178
2015
Q1
Sell
-4,398,877
Closed -$288M 624
2014
Q4
$288M Buy
4,398,877
+515,347
+13% +$32.5M 1.39% 11
2014
Q3
$224M Buy
3,883,530
+1,652,372
+74% +$91.7M 1.09% 18
2014
Q2
$126M Sell
2,231,158
-10,793
-0.5% -$566K 0.62% 42
2014
Q1
$115M Buy
2,241,951
+2,073,643
+1,232% +$105M 0.57% 50
2013
Q4
$8.89M Buy
168,308
+69
+0% +$3.39K 0.05% 305
2013
Q3
$7.53M Sell
168,239
-298,132
-64% -$13.2M 0.04% 312
2013
Q2
$19.3M Buy
+466,371
New +$20.4M 0.11% 191

Other funds holding ABBV

Fred Alger Management's ABBV Position: Q1 2026 in Review

Fred Alger Management reduced its AbbVie (ABBV) stake by 4.4% in Q1 2026, selling an estimated $1.11M and leaving 108,818 shares worth $23.7M. The position accounts for 0.1% of the portfolio, ranked #101.

Fred Alger Management first reported a position in ABBV in Q2 2013 and has held it in 50 quarters since. The position peaked at $288M in Q4 2014. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Fred Alger Management held 108,818 shares of AbbVie worth $23.7M as of Q1 2026.
  • Fred Alger Management sold 5,008 AbbVie shares in Q1 2026, an estimated $1.11M.
  • AbbVie made up 0.1% of Fred Alger Management's portfolio in Q1 2026, its #101 holding.
  • Fred Alger Management first reported a position in AbbVie in Q2 2013 and has held it in 50 quarters since.
  • Fred Alger Management's AbbVie position peaked at $288M in Q4 2014.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.